Weighing Alli's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill.

Autor: Cumella EJ; Remuda Programs for Eating Disorders, USA. edward.cumella@remudaranch.com, Hahn J, Woods BK
Jazyk: angličtina
Zdroj: Behavioral healthcare [Behav Healthc] 2007 Jun; Vol. 27 (6), pp. 32-4.
Databáze: MEDLINE